Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial ...
Introduction Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular disease characterized by progressive occlusion of pulmonary arteries, leading to a gradual increase in pulmonary vascular resistance and subsequent right ventricular …